PharmOptima, a Genesis Drug Discovery and Development (GD3) Company, has been advancing drug discovery and development in various therapeutic areas and has filled a niche in ocular drug development since 2003. PharmOptima’s in vivo services include studies in the fields of drug absorption, distribution, metabolism, and excretion (ADME), pharmacokinetics (PK), and pharmacology. It provides liquid chromatography and mass spectrometry (LC-MS/MS) bioanalysis in support of discovery and development programs, including method development and validation in accordance with regulatory guidelines. Its biochemistry expertise allows them to assess the role of biomarkers in numerous disease models. PharmOptima’s biochemical capabilities include in vitro and cell based assay development for compound profiling as well as protein cloning and expression. Its expertise extends to the custom development of enzyme-linked immunosorbent assays (ELISA) and electrochemiluminescence multiplex formats.

Biotechnology

Health Care

Life Sciences

Pharmaceutical

PharmOptima™

The Portage office focuses on assay development and scientific research, driving innovations in biotechnology and pharmaceuticals.

PharmOptima™

Org chart

Teams

Offices

PharmOptima™

Org chart

Teams

Offices

Related companies